(Q71809603)

English

The in vitro activity of cefotaxime versus bacteria involved in selected infections of hospitalized patients outside of the intensive care unit

scientific article published on 01 May 1995

In more languages

default values for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7587027%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

The in vitro activity of cefotaxime versus bacteria involved in selected infections of hospitalized patients outside of the intensive care unit (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7587027%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

intensive care unit

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

G. V. Doern

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7587027

26 May 2024

language of work or name

1 reference

National Center for Biotechnology Information

PubMed publication ID

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=7587027

26 May 2024

publication date

1 May 1995

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7587027%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

full work available at URL

https://api.elsevier.com/content/article/PII:073288939500050K?httpAccept=text/xml

1 reference

10.1016/0732-8893(95)00050-K

https://api.crossref.org/works/10.1016/0732-8893(95)00050-K

26 May 2024

https://api.elsevier.com/content/article/PII:073288939500050K?httpAccept=text/plain

1 reference

10.1016/0732-8893(95)00050-K

https://api.crossref.org/works/10.1016/0732-8893(95)00050-K

26 May 2024

Diagnostic Microbiology and Infectious Disease

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7587027%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

22

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7587027%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

1-2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7587027%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

13-17

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7587027%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

Antimicrobial susceptibility of Arcanobacterium haemolyticum

2

1 reference

10.1016/0732-8893(95)00050-K

https://api.crossref.org/works/10.1016/0732-8893(95)00050-K

26 May 2024

In vitro activities of 39 antimicrobial agents for Branhamella catarrhalis and comparison of results with different quantitative susceptibility test methods

4

1 reference

10.1016/0732-8893(95)00050-K

https://api.crossref.org/works/10.1016/0732-8893(95)00050-K

26 May 2024

Management of infections caused by antibiotic-resistant Streptococcus pneumoniae

5

1 reference

10.1016/0732-8893(95)00050-K

https://api.crossref.org/works/10.1016/0732-8893(95)00050-K

26 May 2024

In vitro activity of 79 antimicrobial agents against Corynebacterium group D2.

6

1 reference

10.1016/0732-8893(95)00050-K

https://api.crossref.org/works/10.1016/0732-8893(95)00050-K

26 May 2024

Antimicrobial Activity of Desacetylcefotaxime Alone and in Combination with Cefotaxime: Evidence of Synergy

8

1 reference

10.1016/0732-8893(95)00050-K

https://api.crossref.org/works/10.1016/0732-8893(95)00050-K

26 May 2024

Cefotaxime: A Review of in Vitro Antimicrobial Properties and Spectrum of Activity

9

1 reference

10.1016/0732-8893(95)00050-K

https://api.crossref.org/works/10.1016/0732-8893(95)00050-K

26 May 2024

Comparison of a new cephalosporin, BMY 28142, with other broad-spectrum beta-lactam antibiotics

10

1 reference

10.1016/0732-8893(95)00050-K

https://api.crossref.org/works/10.1016/0732-8893(95)00050-K

26 May 2024

Susceptibility of Campylobacter pyloridis to 20 antimicrobial agents

11

1 reference

10.1016/0732-8893(95)00050-K

https://api.crossref.org/works/10.1016/0732-8893(95)00050-K

26 May 2024

Cephalosporins — Cefotaxime 10 years later, a major drug with continued use

14

1 reference

10.1016/0732-8893(95)00050-K

https://api.crossref.org/works/10.1016/0732-8893(95)00050-K

26 May 2024

Antibacterial Activity of Desacetylcefotaxime Alone and in Combination with Cefotaxime

15

1 reference

10.1016/0732-8893(95)00050-K

https://api.crossref.org/works/10.1016/0732-8893(95)00050-K

26 May 2024

Extended-spectrum beta-lactamases

16

1 reference

10.1016/0732-8893(95)00050-K

https://api.crossref.org/works/10.1016/0732-8893(95)00050-K

26 May 2024

Antimicrobial susceptibility of pathogenic Yersinia enterocolitica isolated in Canada from 1972 to 1990.

17

1 reference

10.1016/0732-8893(95)00050-K

https://api.crossref.org/works/10.1016/0732-8893(95)00050-K

26 May 2024

Chromosomal cephalosporinases responsible for multiple resistance to newer beta-lactam antibiotics

18

1 reference

10.1016/0732-8893(95)00050-K

https://api.crossref.org/works/10.1016/0732-8893(95)00050-K

26 May 2024

Pharmacokinetics and Bacteriologic Efficacy of Moxalactam, Cefotaxime, Cefoperazone, and Rocephin in Experimental Bacterial Meningitis

19

1 reference

10.1016/0732-8893(95)00050-K

https://api.crossref.org/works/10.1016/0732-8893(95)00050-K

26 May 2024

Antibacterial activity of cefotaxime and other newer cephalosporins (in vitro and in vivo)

20

1 reference

10.1016/0732-8893(95)00050-K

https://api.crossref.org/works/10.1016/0732-8893(95)00050-K

26 May 2024

Antimicrobial susceptibilities of Corynebacterium species and other non-spore-forming gram-positive bacilli to 18 antimicrobial agents

21

1 reference

10.1016/0732-8893(95)00050-K

https://api.crossref.org/works/10.1016/0732-8893(95)00050-K

26 May 2024

In vitro susceptibility of Campylobacter jejuni to 27 antimicrobial agents and various combinations of beta-lactams with clavulanic acid or sulbactam

23

1 reference

10.1016/0732-8893(95)00050-K

https://api.crossref.org/works/10.1016/0732-8893(95)00050-K

26 May 2024

Activity of the cefotaxime (HR756) desacetyl metabolite compared with those of cefotaxime and other cephalosporins

24

1 reference

10.1016/0732-8893(95)00050-K

https://api.crossref.org/works/10.1016/0732-8893(95)00050-K

26 May 2024

Identifiers

10.1016/0732-8893(95)00050-K

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7587027%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7587027%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q71809603&oldid=2164922180"